Table 1

Demographic characteristics of patients who underwent TLIF vs PLF.

VariablesTLIF (N = 591)PLF (N = 259) P Value
Age, y, mean ± SD59.0 ± 11.363.3 ± 12.6 <0.001a
Gender (men), n (%)258 (43.7)119 (46.1)0.518
Race (White), n (%)523 (88.5)230 (88.8)0.263
BMI, mean ± SD31.3 ± 6.630.2 ± 12.6 0.019a
Comorbidities, n (%)
 0114 (19.3)41 (15.8)0.472
 1–2365 (61.7)165 (63.7)
 >2112 (20.0)53 (20.5)
 Hypertension352 (59.6)166 (64.1)0.213
 Diabetes mellitus115 (19.5)54 (20.8)0.640
 CAD85 (14.4)38 (14.8)0.912
 CHF12 (2.0)4 (1.5)0.631
 COPD18 (3.0)12 (4.6)0.248
 Osteoporosis11 (1.9)8 (3.1)0.265
Active smoker, n (%)92 (15.6)28 (10.8)0.071
Insurance, n (%)a 0.001a
 Private297 (50.3)101 (39.0)
 Public231 (39.1)140 (54.1)
 Military59 (10.0)18 (7.3)
 Uninsured3 (0.5)0 (0.0)
Currently employed, n (%)271 (45.9)87 (33.6) 0.001a
Return to work, n (%)219 (80.8)70 (80.4)0.645
Preoperative ambulation, n (%)0.530
 Independent433 (73.3)181 (69.9)
 With assistance153 (25.9)77 (29.7)
 Wheelchair-bound2 (0.3)1 (0.4)
Duration of symptoms, n (%)a 0.684
 <3 mo29 (6.0)9 (4.6)
 3–12 mo127 (26.3)49 (25.0)
 >12 mo326 (67.6)138 (70.4)
Diagnosis, n (%)0.199
 Stenosis119 (20.1)48 (18.5)
 Pseudarthrosis3 (0.5)0 (0.0)
 Spondylolisthesis413 (69.9)185 (71.4)
 Other56 (9.4)26 (10.0)
  • a Missing values.

  • BMI, body mass index; CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; PLF, posterolateral fusion; TLIF, transforaminal lumbar interbody fusion.